Clinical Trials Logo

Smoking Cessation clinical trials

View clinical trials related to Smoking Cessation.

Filter by:

NCT ID: NCT03999411 Completed - HIV Clinical Trials

Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients

Start date: September 9, 2019
Phase: Phase 4
Study type: Interventional

The purpose of this study is to learn if a mindfulness-based smoking cessation smartphone app can help people quit smoking and stay on antiretroviral therapies.

NCT ID: NCT03996902 Completed - Chronic Pain Clinical Trials

Increasing Cessation Motivation and Treatment Engagement Among Smokers in Pain

Start date: May 10, 2016
Phase: N/A
Study type: Interventional

The goal of this study is to develop and pilot test a brief intervention to increase motivation to quit and smoking cessation treatment engagement among smokers with chronic pain.

NCT ID: NCT03995225 Completed - Smoking Cessation Clinical Trials

Smartband Mindfulness Study

Start date: November 22, 2020
Phase: N/A
Study type: Interventional

To determine treatment fidelity for a smartband/smartphone-based smoking monitoring, notification and brief mindfulness intervention.

NCT ID: NCT03982576 Completed - Smoking Cessation Clinical Trials

Innovations to Prevent Relapse Among Low-income African American Smokers

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this research is to study a relapse prevention program for adult former smokers in Northeast Ohio. The study will also look at how different people respond to the program. Participants asked to take part in this study because they contacted the team for help remaining tobacco-free or otherwise expressed interest in the program. The study includes completing surveys and receiving text messages to help stay tobacco free.

NCT ID: NCT03978455 Completed - Smoking Cessation Clinical Trials

A Pilot Study of the Learn, Connect, and Quit Mobile Application

Start date: June 18, 2019
Phase:
Study type: Observational

This research study aims to develop and test the effectiveness of a mobile application for patients who smoke to use while waiting in the clinic exam room to see their provider. The application will present patients with a variety of videos designed to increase their engagement in evidence-based smoking cessation treatment and offer them action steps to engage in smoking-related treatment or discussions with their provider.

NCT ID: NCT03951766 Completed - Smoking Cessation Clinical Trials

Version 2 of the Smoking Cessation Smartphone App "Smiling Instead of Smoking" (SiS)

Start date: June 24, 2019
Phase: N/A
Study type: Interventional

The overall goal of this pilot study is to solicit feedback from nondaily smokers looking for smoking cessation support online (n=90) about Version 2 of a smartphone app investigators designed to support smoking cessation, and to test if within-person theorized mechanisms of change are occurring as participants undergo the app-assisted quit attempt. Data sources will be passively collected smartphone app usage data, surveys and, in a sub-sample (n=20), online video-conference user feedback sessions. Results will be used to guide the design of Version 3.0 of the "Smiling Instead of Smoking" (SiS) smartphone app. Specifically, the aims of this study are to: 1. Assess ease-of-use and helpfulness of the app, as rated by app users 6 weeks after their chosen smoking cessation date 2. Test if within-person changes occur in theorized mechanisms of behavior change as nondaily smokers undergo a SiS app assisted quit attempt 3. Identify app features in need of improvement, as identified by passively recorded app usage patterns, REDCap open-ended survey items, and, in a sub-sample, user feedback sessions (n=20)

NCT ID: NCT03942146 Completed - Smoking Cessation Clinical Trials

Smoking Cessation Prior to Gynecological Surgery

Start date: November 5, 2015
Phase: N/A
Study type: Interventional

This study evaluates whether current smokers scheduled for gynecological surgery will stop smoking to a higher extent if they or the surgeon is exposed to information on smoking cessation prior to surgery in a web-based questionnaire in the Swedish National quality register for gynecological surgery, GynOp.

NCT ID: NCT03938298 Completed - Smoking Cessation Clinical Trials

The ESTxENDS Trial: Pulmonary Function Substudy

PulmENDS
Start date: April 10, 2019
Phase: N/A
Study type: Interventional

--> This is a substudy of the main ESTxENDS trial (NCT03589989). Pulmonary function outcomes should be considered secondary outcomes of the main smoking cessation outcome formulated in NCT03589989. Cigarette smoking is the leading cause of preventable death in Switzerland and still more than a quarter of the Swiss population smokes cigarettes. Recently, electronic nicotine delivery systems (ENDS; also called vaporizer, e-cigarette or electronic cigarette) have become popular with smokers who want to stop smoking or reduce their exposure to inhaled chemicals since ENDS use appears to be safer than tobacco smoking. The inhaled ENDS aerosol appears safe in laboratory conditions, its long-term effects on pulmonary function remains unknown. This study will therefore investigate the impact of ENDS on lung function in smokers, who attempt to quit using ENDS compared with smokers, receiving only smoking cessation counseling with nicotine replacement therapy (NRT). Multiple breath washout (MBW) is an established technique for assessment of peripheral airway function in pediatrics and its use is emerging in adult medicine, as it offers a better sensitivity to assess small airway disease before large airway involvement can be detected using conventional pulmonary function tests (PFT - spirometry, body plethysmography and diffusing capacity test). Preliminary evidence from limited studies suggest MBW parameters (LCI, Scond, Sacin) can be impaired in smokers with normal lung function and improve after smoking abstinence. Primary objective of this substudy is to assess changes in LCI from baseline to 6 months post target quit date (TQD) in cigarette smokers randomized to the intervention group compared to the control group. For the main ESTxENDS trial (NCT03589989), cigarette smokers motivated to quit smoking cigarettes will be included. Participants in the intervention group will receive an ENDS and nicotine-containing e-liquids, which they will be allowed to use ad libitum. Additionally, they will receive standard of care, i.e. smoking cessation counseling and encouragement to use NRT. Smoking cessation counseling will be provided in person at the first clinical visit and then over the phone at the target quit date and again at week 1, 2, 4 and 8 after the target quit date. Participants in the control group will receive only standard of care. All participants will be followed over a 6-month period. After 6 months, participants will be asked to come to a final clinical visit.

NCT ID: NCT03930329 Completed - Smoking Cessation Clinical Trials

Mindfulness-based Treatment to Prevent Smoking Relapse

Start date: July 24, 2019
Phase: N/A
Study type: Interventional

Background: Smoking causes a variety of health problems and causes burden to healthcare systems. Even when support is provided, local data suggest that around 50% of biochemically confirmed quitters resume smoking within 6 months of participating in a smoking cessation program. Mindfulness-based intervention is a promising option because accumulating evidence from randomized controlled trials support its use among smokers. Our team aims to determine if mindfulness-based interventions can prevent relapse in smokers who recently quit smoking. A pilot trial is needed to determine the feasibility of recruitment, randomisation and acceptability of the intervention in these patients Method: Forty participants, who just quitted smoking, will be randomised in a 1:1 ratio to the 8week mindfulness-based relapse prevention (MBRP) program and to usual care.

NCT ID: NCT03929003 Completed - Smoking Cessation Clinical Trials

Inspired: Smartphone Videogame-Based Smoking Cessation Intervention

Start date: April 5, 2019
Phase: N/A
Study type: Interventional

The investigators are testing a new, smartphone videogame-based intervention for smoking cessation.